The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Novel roles for Slits and netrins: axon guidance cues as anticancer targets?
Open accessAbstract
Netrin 1 and members of the Slit family and their receptors are deregulated in a large proportion of human cancers, suggesting that they could be tumour suppressor genes or oncogenes. Evidence for and against these functions is discussed, along with recent data that these ligand–receptor pairs could be promising targets for personalized anticancer therapies. Over the past few years, several genes, proteins and signalling pathways that are required for embryogenesis have been shown to regulate tumour development and progression by playing a major part in overriding antitumour safeguard mechanisms. These include axon guidance cues, such as Netrins and Slits. Netrin 1 and members of the Slit family are secreted extracellular matrix proteins that bind to deleted in colorectal cancer (DCC) and UNC5 receptors, and roundabout receptors (Robos), respectively. Their expression is deregulated in a large proportion of human cancers, suggesting that they could be tumour suppressor genes or oncogenes. Moreover, recent data suggest that these ligand–receptor pairs could be promising targets for personalized anticancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Stein, E., & Tessier-Lavigne, M. (2001) · Science · doi:10.1126/science.1058445 · Cited by 601
RetractedStein, E., Zou, Y., Poo, M.-M., & Tessier-Lavigne, M. (2001) · Science · doi:10.1126/science.1059391 · Cited by 242
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
The Molecular Biology of Axon Guidance
Tessier-Lavigne, M., & Goodman, C. S. (1996) · Science · doi:10.1126/science.274.5290.1123 · Cited by 3,278
Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers
Fearon, E. R., Cho, K. R., Nigro, J. M., Kern, S. E., Simons, J. W., Ruppert, J. M., Hamilton, Preisinger, A. C., Thomas, G., Kinzler, K. W., et al. (1990) · Science · doi:10.1126/science.2294591 · Cited by 1,739
The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6
Serafini, T., Kennedy, T. E., Gaiko, M. J., Mirzayan, C., Jessell, T. M., & Tessier-Lavigne, M. (1994) · Cell · doi:10.1016/0092-8674(94)90420-0 · Cited by 1,373
Netrins are diffusible chemotropic factors for commissural axons in the embryonic spinal cord
Kennedy, T. E., Serafini, T., de la Torre, J., & Tessier-Lavigne, M. (1994) · Cell · doi:10.1016/0092-8674(94)90421-9 · Cited by 1,338
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
Pasquale, E. B. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2806 · Cited by 1,226
Deleted in Colorectal Cancer (DCC) Encodes a Netrin Receptor
Keino-Masu, K., Masu, M., Hinck, L., Leonardo, E. D., Chan, S. S.-Y., Culotti, J. G., & Tessier-Lavigne, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81336-7 · Cited by 1,013
Slit Is the Midline Repellent for the Robo Receptor in Drosophila
Kidd, T., Bland, K. S., & Goodman, C. S. (1999) · Cell · doi:10.1016/s0092-8674(00)80589-9 · Cited by 949
Cited by
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Initiative, A. P. C. G., Biankin, A. V., Waddell, N., Kassahn, K. S., Gingras, M.-C., Muthuswamy, L. B., Johns, A. L., Miller, D. K., Wilson, P. J., Patch, A.-M., et al. (2012) · Nature · doi:10.1038/nature11547 · Cited by 2,058
Targeting skeletal endothelium to ameliorate bone loss
Xu, R., Yallowitz, A., Qin, A., Wu, Z., Shin, D. Y., Kim, J.-M., Debnath, S., Ji, G., Bostrom, M. P., Yang, X., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0020-z · Cited by 374
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
Neophytou, C. M., Trougakos, I. P., Erin, N., & Papageorgis, P. (2021) · Cancers · doi:10.3390/cancers13174363 · Cited by 371
Nerve–Cancer Cell Cross-talk: A Novel Promoter of Tumor Progression
Jobling, P., Pundavela, J., Oliveira, S. M. R., Roselli, S., Walker, M. M., & Hondermarck, H. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3180 · Cited by 272
“In addition, cancer cells have been shown to secrete axon guidance molecules such as netrins (16, 17), and it could be hypothesized that these molecules also contribute to facilitate nerve infiltration.”
BackgroundStructural Decoding of the Netrin-1/UNC5 Interaction and its Therapeutical Implications in Cancers
Grandin, M., Meier, M., Delcros, J. G., Nikodemus, D., Reuten, R., Patel, T. R., Goldschneider, D., Orriss, G., Krahn, N., Boussouar, A., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.01.001 · Cited by 128
Self-citationDependence Receptors and Cancer: Addiction to Trophic Ligands
Gibert, B., & Mehlen, P. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3652 · Cited by 73
“Along this line, netrin-1 was found to be overexpressed in a large variety of tumor types such as breast, lung, ovarian cancer, neuroblastoma, and medulloblastoma (32, 33).”
BackgroundSelf-citationFan, S., Tang, J., Li, N., Zhao, Y., Ai, R., Zhang, K., Wang, M., Du, W., & Wang, W. (2019) · npj Genomic Medicine · doi:10.1038/s41525-019-0077-8 · Cited by 48
Dependence receptors and colorectal cancer
Mehlen, P., & Tauszig-Delamasure, S. (2014) · Gut · doi:10.1136/gutjnl-2013-306704 · Cited by 44
Self-citationThe Dependence Receptor TrkC Triggers Mitochondria-Dependent Apoptosis upon Cobra-1 Recruitment
Ichim, G., Genevois, A.-L., Ménard, M., Yu, L.-Y., Coelho-Aguiar, J. M., Llambi, F., Jarrosson-Wuilleme, L., Lefebvre, J., Tulasne, D., Dupin, E., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.021 · Cited by 28
“Oneway to silence this death pathway is by upregulating the receptors’ ligands (Delloye-Bourgeois et al., 2009a; DelloyeBourgeois et al., 2009b; Mehlen et al., 2011; Mehlen and Puisieux, 2006).”
BackgroundSelf-citation
Metadata
- Authors
- Mehlen, P., Delloye-Bourgeois, C., & Chédotal, A.
- Venue
- Nature Reviews Cancer
- Published
- 2011-02-17
- Volume
- 11
- Issue
- 3
- Pages
- 188-197
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2048888260
- Cited by
- 275
- References
- 120
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.